Skip to main content
Clinical Trials/ACTRN12607000197437
ACTRN12607000197437
Terminated
Not Applicable

A randomised, controlled clinical trial of influenza vaccine in the prevention of recurrent ischaemic vascular events in adult patients with recent myocardial infarction, a transient ischaemic attack or with an ischaemic cerebrovascular event (stroke), aged 40-64 years

ational Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases0 sites500 target enrollmentApril 10, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prevention of recurrent ischaemic vascular events
Sponsor
ational Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
Enrollment
500
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 10, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
ational Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

Eligibility Criteria

Inclusion Criteria

  • Must not have received influenza vaccine in the study year.Consent must be givenHas to be admitted to hospital with either an Acute, evolving or recent myocardial infarction, or a Transient ischaemic attack or with a Ischaemic cerebrovascular event (stroke).

Exclusion Criteria

  • Inability or refusal to consent.Already vaccinated against influenza during the study year Has a medical contraindication to vaccination (egg allergy) or gentamicin Is outside of the specified age groupHas had a Haemorrhagic stroke or chronic cardiac disease including congestive cardiac failure.Guillain\-Barre Syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials